The cost of sales grew to EGP 298.5 million
Minapharm Pharmaceuticals
MIPH
MIPH
Cairo – Mubasher: Minapharm Pharmaceuticals on Wednesday reported a 51% year-on-year profit decline during the first quarter of 2019, recording EGP 6.48 million.
Net sales went up to EGP 384.85 million in Q1-19, compared to EGP 336.36 million a year earlier.
Meanwhile, the cost of sales grew to EGP 298.5 million in the first three months of this year, against EGP 247.2 million in 2018.
In 2018, Minapharm’s net sales reached EGP 72.12 million.
Source:
Mubasher
